Copenhagen, Denmark

Vincent Ellis


Average Co-Inventor Count = 9.5

ph-index = 4

Forward Citations = 43(Granted Patents)


Location History:

  • Copenhagen, DK (1996 - 2001)
  • Woodford Green, GB (2000 - 2001)

Company Filing History:


Years Active: 1996-2001

Loading Chart...
6 patents (USPTO):Explore Patents

Title: **The Innovative Contributions of Vincent Ellis**

Introduction

Vincent Ellis, an accomplished inventor based in Copenhagen, Denmark, has made significant strides in the field of biomedical research, particularly in cancer treatment technologies. With a total of six patents to his name, his innovations are poised to impact the medical industry profoundly.

Latest Patents

Among his latest inventions, Ellis has developed a patent related to the Urokinase-type plasminogen activator receptor. This invention addresses the inhibition of plasminogen conversion to plasmin by preventing the binding of the receptor form of urokinase-type plasminogen activator. This method is aimed at preventing plasmin formation in mammals, showcasing a potential pathway for new therapeutic strategies.

Furthermore, he has also patented a methodology for suppressing inhibitors that contribute to malignant tumor growth, invasion, and metastasis. This invention outlines techniques for inhibiting the activity of protease or non-proteolytic matrix-degrading enzyme inhibitors (IPNME) in malignant tissues. The approach may involve administering compounds that interact with these inhibitors, as well as methods for selecting therapeutic compounds for treating malignancies.

Career Highlights

Vincent Ellis's career is distinguished by his affiliation with notable organizations in the cancer research field. He has been associated with Cancer Research Foundation of 1989, where he leveraged his expertise to contribute to advancements in cancer treatment methodologies. His work is characterized by a strong focus on developing innovative solutions for complex medical challenges.

Collaborations

Throughout his career, Ellis has worked alongside esteemed colleagues, including Charles Pyke and Niels Behrendt. These collaborations have facilitated a dynamic exchange of ideas, fostering an environment of innovation and scientific inquiry that has helped propel their collective efforts in the field of biomedical research.

Conclusion

Vincent Ellis stands as a prominent figure in innovation within the realm of cancer research. His six patents reflect a commitment to enhancing therapeutic methods that could potentially transform the approach to cancer treatment. With ongoing contributions and collaborative efforts, Ellis continues to pave the way for future advancements in medical sciences.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…